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Alloplastic materials can be used together with tissue and structure to close nasal septal perforation. 
Aim: to test cellulose use in the closure of septal perforation in rabbits and to compare fibrosis, 
inflammation, vascular congestion and graft integrity. 
Materials and Methods: Fifteen rabbits. The rabbits were divided into two groups: Control: Five 
rabbits and Bionext® and fibrin glue Tissucol®: Ten rabbits. Septal perforations were done in all of 
them. In the Bionext® group the closure was performed with the placement of cellulose. 
Results: Two rabbits died in the first week. Cellulose group: 2 closures without the cellulose in 
between the septum membrane and in 4 cases the graft stood in the middle of the perforation locked 
in place by the edges. No closure in the control group. 
Conclusion: There was no closure of the perforation of the nasal septum with the graft between the 
septum membranes. There was no statistically significant difference concerning acute inflammation, 
vascular congestion and fibrosis between the 2 groups. In cases in which the graft remained in 
place, there was no change in its integrity. It may be used as a substructure for reepithelization of 
the perforation edges.
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INTRODUCTION
Nasal septum perforation is a disorder of easy 
diagnosis through the use of a nasal speculum or nasal 
endoscopy in the office. It can have numerous causes, 
from very benign ones, to local manifestations of syste-
mic diseases. Moreover, nasal septum perforation varies 
broadly depending on location, size and symptoms; in 
consequence, many are the treatment options, including 
conservative treatment and numerous surgical techniques. 
Treatment must be customized for each patient.
The main cause of septal perforation is iatrogenic 
- as a complication of nasal surgery1,2; however, other 
iatrogenic causes may happen, such as the use of nasal 
steroids3-5, mucosal cauterization to treat epistaxis; naso-
tracheal intubation and turbinate cryosurgery. Moreover, 
nasal perforations have been described after many types 
of trauma surgery. Perforation rarely happens in children6.
Among the diseases associated with nasal perfo-
ration, we list: cutaneous mucosal leishmaniasis; nasal 
abscess; syphilis; tuberculosis; typhoid fever; diphtheria; 
Wegener granulomatosis; lupus erythematous and sar-
coidosis. Neoplasia and carcinomas also can cause nasal 
septum perforation7-9. In tropical, developing areas, leprosy 
and Leishmaniasis still are among the causes of nasal 
septum perforation10,11. When the perforation borders are 
covered by mucosa, hardly the perforation is associated to 
more severe disorders, such as tuberculosis or neoplasias3,1.
Inhaling irritating products can also cause nasal 
septum perforation, such as in cases of nasal aspiration 
of cocaine, which causes ischemia by vasoconstriction1, 
foreign body granuloma caused by substances added to the 
drug3, besides perforations reported after inhaling chro-
mic acid smoke, limo and cement powder, tar, pitch, salt, 
glass powder, sodium cabonate, calcium nitrate, calcium 
cyanide, arsenic, mercury and phosphorus.
Often times, the perforation happens before other 
systemic disease symptoms, and clinical investigation is ne-
cessary for those cases without clear etiological diagnosis12.
Nasal septum perforation can be range from asymp-
tomatic to those causing severe epistaxis, nasal cosmetic 
deformities, crust forming and nasal obstruction1-3.
The surgeries proposed to close perforations use 
flaps and grafts. The latter can be autologous (removed 
from the same being), homologous (from another being 
of the same species), heterologous (from another being 
of another species) and alloplastic (synthetic materials). 
Autologous grafts have the main disadvantage of causing 
trauma to the donor areas; and homologous and hetero-
logous grafts bear risk of contamination for the individual 
receiving tissue from another being13.
An inert material which could provide structure 
to the healing would be very useful in the treatment ar-
senal of this disorder. The cellulose film formed by the 
fermentation from Acetobacter xillinum bacteria is inert, 
resistant and insoluble, permeable to liquid and gas and 
resistant to stretching and traction. It is sterile, non-toxic 
and non-pyrogenic14.
Studies in rabbits, replacing the septal cartilage for 
cellulose showed a partial absorption of the cellulose film 
after four weeks15 and when used to cover the open area 
after nasal concha resection in rabbits, it proved tolerable 
to the receiving tissue and there was no difference as to 
the healing response concerning the control group16.
We propose an experimental study to close a nasal 
perforation in rabbits using the cellulose film together 
with fibrin glue used for fixation, and analyze the tissue 
response, graft properties and whether or not the perfo-
ration would be closed.
LITERATURE REVIEW
Using the LILACS and Pubmed databases and the 
Internet, we searched the existing literature in relation to 
the cellulose produced by the Acetobacter xillinum bacte-
ria, its development and use; surgical techniques used to 
close nasal septum perforation and the different materials 
used for this task.
Nasal septum perforation closure surgery in humans
In 1935, Imperatori et al.17 proposed a surgical 
enlargement of the perforation, with the aim of reducing 
the discomfort brought about by constant hissing caused 
by smaller perforations, located on the anterior portion 
of the nasal septum.
The techniques used to close septal perforation 
can be grouped in: those in which we use flaps from the 
nasal septum itself to close it with or without grafts, and 
the techniques which use neighboring flaps.
The papers which suggest flap rotation are unani-
mous as to the need for a second surgical procedure to 
resect the vascular pedicle.
Among the techniques using septal mucosa flaps, 
we find the description of fascia and perichondrium graf-
ting in between the septal mucosa leaflets, by Wright et 
al.18. This publication was greatly important, both because 
of the promising results, as well as for justifying the use of 
grafts to close the perforations, instead of simply suturing 
the borders. The authors also report that, besides the low 
metabolic requirements, fascia and perichondrium grafts 
serve as support for the growth of fibroblasts, supporting 
growth at the margins of the mucosas, one towards the 
other.
McCollough19 reported a successful closure of the 
septal perforation with ear-based graft. In 1980, Fairbanks9 
described temporal fascia use with a diameter 2cm larger 
than the perforation to be covered. This same publication 
advocates that small perforations arising from surgery 
have a better chance of closure if done during the same 
surgical intervention, since the perforation diameter tends 
to increase during healing.
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Fairbanks8 also spoke against surgical techniques 
which propose suturing the borders of the perforation, with 
or without everting the contralateral mucosa because of 
the atrophic and fragile characteristic of the tissue of the 
perforation borders. It also criticizes the techniques which 
use the oral mucosa, considering its non-transformation 
in ciliated tissue, thus having its drying as a consequence.
Suggestions concerning the use of artificial material 
or implants associated with closure techniques were given 
by Gyeney and Kerenyi20 who in 1977 reported the closure 
of septal perforation through fibrin implants (Bioplast®). 
Kridel et al. in 199821 suggested the use of a biosynthetic 
substitute (Acellular Human Dermal Allograft®), having 
reported success in the closure of eleven among 12 per-
forations treated. The authors criticized the use of fascias, 
especially due to the need to use material to dry them, 
which causes early softening, making them difficult to 
handle. In cases of failure, there was a diameter reduction 
from 3cm to 5mm. In 2006, Lee et al.22 showed the use of 
fibrin glue and autologous cartilage grafts used to prevent 
nasal septum perforation during septoplasty.
Other materials such as gold, ivory, cobalt and cork 
have also been used23. Among the most used alloplastic 
materials we find those based on silicone, such as Silastic® 
which are largely used in facial structure surgeries thanks 
to their possibility of being sculptured and molded accor-
ding to need. Although relatively inert from the biological 
standpoint, after its placement on the receiving site, a 
fibrous capsule can cover it with time, causing tangible 
mobility and consequently greater likelihood of migration 
and extrusion24.
Stoor et al.25 studied the septal closure and infection 
by Haemophilus influenza and Streptococcus pneumoniae 
with the use of bioactive glass (BAG) in 11 patients with 
septal perforation not having contamination by these ger-
ms in any patient and being able to close the perforation 
in 10 cases.
The cellulose film
The Bionext® cellulose film arises from the fermen-
ting of Acetobacter xylinum bacteria, done through the 
experiment carried out by microbiologist Luís Fernando 
Xavier Farah (1984) from Curitiba (PN).26
The cellulose produced by the bacteria can be 
in the form of a flexible, semitransparent and yellowish 
membrane, or as a solid, dense, malleable mantle, of firm 
and jelly-like consistency, of about 0.5cm thick (Figure 
1). The film arising from the biological production of the 
bacteria, after processing, does not have additives, being 
pure cellulose, made up of polysaccharides, biodegradable, 
non-toxic, non-pyrogenic and sterile. It is an inert substan-
ce, very resistant and insoluble in all organic solvents, and 
it has specific physical characteristics, such as: established 
permeability defined to liquids and gases, resistance to 
traction and stretching, also having characteristic weight 
and molecular structure.14,27,28
It is efficient for pain relief and to reduce healing 
time in dermoabrasion lesions, skin donor areas, or in 
large burns. This composite has been successfully used 
as bandage in skin sores, burns and skin donor areas. It 
was also used as substitute for meninges.29-34
It is seen as a material of numerous possibilities, 
from paper to protect documents to bullet proof vests26. 
Acetobacter xilinum comercial cellulose, Bionext®, has 
been approved by ANVISA and the FDA and is used as a 
transitional skin replacement. Its physical and biocompa-
tibility properties, as well as its ease of use and the possi-
bility of modeling during insertion makes this substance 
a possible element in the treatment of bone and cartilage 
together.
OBJECTIVES
1. To test the use of cellulose produced by Ace-
tobacter xylinum bacteria -Bionext® together with the 
Tissucol® biological fibrin glue in the closing of septal 
perforation surgically inflicted in rabbits.
2. To histologically compare the degree of fibrosis, 
vascular congestion in the animals, graft integrity and 
whether or not the septal perforation was closed.
MATERIALS AND METHODS
Materials
For this study we used fifteen adult New Zealand 
rabbits weighing approximately 3kg, cellulose mantle 
(Bionext®) and fibrin biological glue (Tissucol®).
Sample size and selection
The rabbits were randomly assigned (coin flip) 
Figure 1. The cellulose mantle being sculptured.
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into two groups: Control Group made up of five rabbits; 
and the Bionext® group associated with the fibrin glue 
Tissucol®, made up of 10 rabbits.
One rabbit from each group died in the immediate 
post-op. the rabbits were slaughtered fifty days after the 
experiment.
Surgical procedure
The surgical procedures were carried out following 
the ethical principles of experimentation with animals, set 
forth by the Brazilian Code of Animal Experimentation 
(COBEA). Protocol 09/07 ICAO.
The surgical procedures were done with the rab-
bits under general anesthesia, using Zoletil® (Tiletamine 
associated with Zolazepan) and Nilperidol® (Fentanyl 
associated with Droperidol) and kept under spontaneous 
ventilation, in dorsal decubitus. They were submitted to 
nasal septum perforation as per described below:
1. 2% lidocaine and noradrenaline soaked cotton in 
the concentration of 1:50,000 in both nasal cavities.
2. Bilateral subperichondrial septum injection of 
the same solution.
3. Upper left-side anterior septal incision followed 
by ipsilateral subperichondrial detachment.
4. Square-shaped incision and removal of appro-
ximately 7mm measured with a surgical caliper, on each 
side of the septal mucosa and septal cartilage.
The experimental group was submitted to the 
placement of the Bionext® graft in the same procedure 
when the perforation was made; anchored in between the 
remaining septal mucosa, which were previously detached 
and not removed (Fig.2).
septum perforation and underwent histopathology analysis 
of the surgical specimen.
For the slaughter at the end of the follow up period, 
the rabbits were again anesthetized and received IV sodium 
thiopental (dose 40mg/kg). After the slaughter, the facial 
mesostructure was removed en bloc for histopathology 
purposes.
The rabbits were evaluated by clinical parameters 
which could indirectly assess tolerability issues, such 
as general and breathing discomfort. The parameters 
evaluated were: amount of food ingested, rabbit weight 
variation, temperature, respiratory rate and the presence 
of nasal bleeding. All the rabbits were weighed before the 
procedure and on a daily basis until their slaughter. The 
amount of food ingested was controlled daily in grams. 
Ear temperature, in Celsius was measured twice a day. 
Respiratory rate was checked twice-a-day. Bleeding was 
seen daily.
The animals’ facial mesostructures were dissected 
and fixed in a 10%  formaldehyde solution. 
Histological evaluation
The animals’ facial mesostructures remained for 6 
days in a 5% nitric acid solution for decalcification. Once 
decalcified, the nose and skull were sliced in 5mm cross-
sections. The slices were then dehydrated, clarified and 
included in paraffin. After inclusion in the paraffin blocs, 
the specimens were cut in the microtome at an average 
thickness of 5μm. (Figure 3)
Figure 2. Rabbit positioned and anesthetized for the procedure.
The rabbits were kept under the same daily care 
conditions as they were prior to treatment, for 50 days, 
when they were slaughtered for observation of the nasal 
Figure 3. Photomicrography of septum histology slides. A - Ruptured 
septum (macro). HE dye.
The slices were then dyed with hematoxylin-eosin 
and the tissue response patterns were histologically asses-
sed. We analyzed: whether or not there was an inflamma-
tory process; Bionext® (ibt) integrity; fibrosis; congestion 
and whether or not the septum perforation had been 
closed (Table 1). The slides were analyzed by only one 
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pathologist in a blind way as to germ group and species, 
and classified in degrees by qualitative and semiquantita-
tive criteria. Thus, Bionext® (IBT) integrity was classified 
in: 0=not applicable/ Bionext® absent, 1= intact and 2= 
fragmented (Figure 4); vascular congestion: 0= absent, 1= 
mildly congested, 2= dilated and congested, and 3= highly 
dilated vessels with red blood cell extravasation (Fig. 5); 
Fibrosis: 0=absent, 1= presence of fibroblasts alone and 
2= reparative fibroblastic proliferation with thickness; 
acute inflammation (AI): we also looked for fibrin and 
neutrophilic exudate: 0=absent, 1= scattered spots and 
2= neutrophil build up involving the structures (Fig. 6).
RESULTS
Two rabbits died in the first week of the experi-
ment, one from the Bionext® group and one from the 
Control Group.
On Table 1 we see the parameters assessed from 
each rabbit, according to their weight in the beginning of 
the experiment and after treatment, and the histological 
characteristics assessed on the specimens analyzed. 
On Table 2 we see the data regarding the graft beha-
vior and whether or not the septal perforation was closed.
DISCUSSION
Because of the need for a framework for fibroblasts 
to grow - supporting growth at the margins of the mucosa, 
one towards the other through a simple border suturing18,2, 
we considered the possibility of using a cellulose film pla-
ced between the borders of a surgical perforation done to 
the nasal septum of rabbits in order to serve as a support 
for a possible tissue regeneration. 
Because the perforation and repair surgery were 
carried out in the same procedure and with the film 
already in place since the onset of the healing process, 
we did not have atrophic margins and we had very little 
vascularization, which is common in the clinical practice 
and does not foster closure8. This is a bias in our study.
Knowing of the ease in intraoperative handling, 
although of little adhesiveness, we added biological glue 
to the margins of the perforation with the aim of fixing 
the film. Thus, the experiment would be similar to the 
one from Kridel et al., who in 1998, who suggested the 
use of biosynthetic substitute (Acellular Human Dermal 
Allograft®) fixed with suture points to one of the sides and 
the other one is closed with mucosa flap rotation; none-
theless, in our case we used cellulose film and biological 
glue without closing the mucosa in any of the sides of 
the perforation.21
Figure 4. Percentage of animals that presented or did not present 
biomaterial integrity, in the control group (without) and experimental 
group (with Bio). (Fisher test: p=0.462).
Figure 5. Percentage of animals who had or did not have congestion, 
in the control (without) and experimental (with bio) groups. (Fisher 
test: p=0.308).
Figure 6. Percentage of animals who had or did not have an acute 
inflammatory process, in the control (without) and experimental (with 
bio) groups.
(Fisher Test: p=0.706)
Statistical Assessment
We compared the results from the Control and 
Bionext® groups by means of the F test of independent 
samples with non-paired comparisons between the groups 
as a whole. For parameters with discontinuing categorical 
values, such as the degree of inflammation, we used the 
Wilcoxon non-parametric test.
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The film incorporation and absorption were more 
significant after four weeks in the studies by Oliveira15 
studying the replacement of the septal cartilage for cellu-
lose film. For this reason we chose to assess our sample 
after 50 days.
All the studies carried out evaluating the cellulose 
film had it in contact with some tissue, we found it inte-
resting to assess its behavior when it is attached only to 
the borders of the perforation.
The perforation closure with the cartilage repla-
cement for the cellulose did not happen. In the cases in 
which the perforation closed, either the cellulose film 
was kept attached to the perforation’s epithelized bor-
ders like a “cork” (Fig. 7), or it was lost very likely due to 
graft shifting. In the cases in which the closure happened 
without the graft (Fig. 8), the question remains whether 
or not the graft helps close the perforation, and at what 
time the shifting happened. Despite the lack of statistical 
significance, we can suspect the film helped in the closure 
since the control group did not show any closure of the 
perforated septa; and such significance was due to the 
small number of rabbits in the sample.
The graft shifting may have happened because of 
the smooth surface of the cellulose film, and due to the lack 
of efficacy of the fibrin glue in contact with the cellulose or 
Table 1. Distribution of the rabbits as to the treatment given, weight (g) and histopathology parameters analyzed.
Rabbit
With 
Bionext
W/out Weight pre Weight post bti ai Cong fibrosis Septum
1 x  5100 6200 0 0 2 0 Ruptured
2  X 4080 4237 0 0 3  0 Ruptured
3 x  3517 3691 0 0 2 0 Closed
4 x  4167 4180 0 0 1 0 Closed
5  X 4157 4238 0 0 2 0 Ruptured
6  X 3438 3751 0 0 0 0 Ruptured
7  X 3570 3693 0 2 3 0 Ruptured
8 x  3150 3774 0 0 3 0 Ruptured
9 x  3305 3508 1 1 1 0 Bt
10 x  3210 3109 0 0 2 0 Ruptured
11 x  3200 3422 0 0 2 0 Closed
12 x  3230 3247 1 1 2 0 Bt
13 x  3185 3392 0 0 2 0 Closed
bti =biotissue integrity (0=not applicable/ Bionext® absent, 1= intact and 2= fragmented); ai= acute inflammation (fibrin and neutrophilic exu-
date: 0=absent, 1= scattered spots and 2= neutrophil build up involving the structures); cong= vascular congestion:( 0= absent, 1= mildly 
congested, 2= dilated and congested and 3= vessels highly dilated with red blood cell spill over); fibrosis: (0=absent, 1= scattered fibroblasts 
and 2= reparative fibroblastic proliferation with thickening) and septum (Bt= Bionext® between the perforation borders)
Table 2. Histological changes seen in relation to the integrity of 
the biomaterial and characteristics of the septum, according to the 
group studied.
Groups n BTI SEPTUM
  0 1 Ruptured Bionext® Closed
With  Bio 9 7 2 3 2 4
W/out 4 4 0 4 0 0
Bionext®: Cellulose present between the borders of the perforation
We did not notice statistically significant difference between the 
groups as to biomaterial integrity (BTI) (p=0.462) and septum closure 
(p=0.176).
Figure 7. Photomicrography of septum histology slides: E=Ruptured 
septum and Bionext® (10x); BT= Bionext® HE dye.
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by the mechanical force of sneezes. Postoperative packing 
for a long period of time, such as the 12 days proposed 
by Kratz in 197335 or for shorter periods such as the two 
days proposed by Lee in 200836 is not feasible in rabbits 
with a delicate graft on the nasal septum.
The lack of statistically significant difference as far 
as  acute inflammation, vascular congestion and fibrosis 
are concerned, prove that the implant is inert and well 
accepted by the nasal mucosa.
The weight gain of the group submitted to the graft 
shows it is well tolerated by the animals and also shows 
little suffering with the experiment.
CONCLUSIONS
a) There was no statistically significant difference 
concerning acute inflammation, vascular congestion and 
fibrosis between the two groups.
b) In the cases in which the graft was kept positio-
ned, there was no change to its integrity.
c) It can be useful in the therapeutic weaponry 
as a basis for reepithelization of the perforation borders.
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